158 related articles for article (PubMed ID: 37377218)
21. The effects of REG4 expression on chemoresistance of ovarian cancer.
Xiang LW; Xue H; Ha MW; Yu DY; Xiao LJ; Zheng HC
J Obstet Gynaecol; 2022 Oct; 42(7):3149-3157. PubMed ID: 35929918
[TBL] [Abstract][Full Text] [Related]
22. The clinicopathological significances and related signal pathways of BTG3 mRNA expression in cancers: A bioinformatics analysis.
Zheng HC; Xue H; Zhang CY; Shi KH; Zhang R
Front Genet; 2022; 13():1006582. PubMed ID: 36186486
[TBL] [Abstract][Full Text] [Related]
23. BAG3 promotes chondrosarcoma progression by upregulating the expression of β-catenin.
Shi H; Chen W; Dong Y; Lu X; Zhang W; Wang L
Mol Med Rep; 2018 Apr; 17(4):5754-5763. PubMed ID: 29484408
[TBL] [Abstract][Full Text] [Related]
24. miR-206 Inhibits Cell Proliferation, Migration, and Invasion by Targeting BAG3 in Human Cervical Cancer.
Wang Y; Tian Y
Oncol Res; 2018 Jul; 26(6):923-931. PubMed ID: 29295729
[TBL] [Abstract][Full Text] [Related]
25. Identification of genes and genetic networks associated with BAG3‑dependent cell proliferation and cell survival in human cervical cancer HeLa cells.
Furusawa Y; Yunoki T; Hirano T; Minagawa S; Izumi H; Mori H; Hayashi A; Tabuchi Y
Mol Med Rep; 2018 Oct; 18(4):4138-4146. PubMed ID: 30106105
[TBL] [Abstract][Full Text] [Related]
26. BAG3 induces α-SMA expression in human fibroblasts and its over-expression correlates with poorer survival in fibrotic cancer patients.
De Marco M; Del Papa N; Reppucci F; Iorio V; Basile A; Falco A; Iaccarino R; Brongo S; De Caro F; Capunzo M; Turco MC; Rosati A; Marzullo L
J Cell Biochem; 2022 Jan; 123(1):91-101. PubMed ID: 34741483
[TBL] [Abstract][Full Text] [Related]
27. BAG3 increases the invasiveness of uterine corpus carcinoma cells by suppressing miR-29b and enhancing MMP2 expression.
Habata S; Iwasaki M; Sugio A; Suzuki M; Tamate M; Satohisa S; Tanaka R; Saito T
Oncol Rep; 2015 May; 33(5):2613-21. PubMed ID: 25738313
[TBL] [Abstract][Full Text] [Related]
28. BAG3 regulates motility and adhesion of epithelial cancer cells.
Iwasaki M; Homma S; Hishiya A; Dolezal SJ; Reed JC; Takayama S
Cancer Res; 2007 Nov; 67(21):10252-9. PubMed ID: 17974966
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.
Kariri YA; Joseph C; Kurozumi S; Toss MS; Alsaleem M; Raafat S; Mongan NP; Aleskandarany MA; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jan; 179(2):349-357. PubMed ID: 31679074
[TBL] [Abstract][Full Text] [Related]
30. PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation.
Li X; Li X; Hu Y; Liu O; Wang Y; Li S; Yang Q; Lin B
BMC Cancer; 2023 Jun; 23(1):573. PubMed ID: 37349676
[TBL] [Abstract][Full Text] [Related]
31. The clinicopathological and prognostic significances of Dkk3 expression in cancers: A bioinformatics analysis.
Chen GY; Zheng HC
Cancer Biomark; 2018; 23(3):323-331. PubMed ID: 29843219
[TBL] [Abstract][Full Text] [Related]
32. BAG3: a multifaceted protein that regulates major cell pathways.
Rosati A; Graziano V; De Laurenzi V; Pascale M; Turco MC
Cell Death Dis; 2011 Apr; 2(4):e141. PubMed ID: 21472004
[TBL] [Abstract][Full Text] [Related]
33. In silico structure evaluation of BAG3 and elucidating its association with bacterial infections through protein-protein and host-pathogen interaction analysis.
Basu S; Naha A; Veeraraghavan B; Ramaiah S; Anbarasu A
J Cell Biochem; 2022 Jan; 123(1):115-127. PubMed ID: 33998043
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression.
Wang HQ; Liu BQ; Gao YY; Meng X; Guan Y; Zhang HY; Du ZX
Br J Pharmacol; 2009 Nov; 158(5):1405-12. PubMed ID: 19681889
[TBL] [Abstract][Full Text] [Related]
35. BAG3 Overexpression and Cytoprotective Autophagy Mediate Apoptosis Resistance in Chemoresistant Breast Cancer Cells.
Das CK; Linder B; Bonn F; Rothweiler F; Dikic I; Michaelis M; Cinatl J; Mandal M; Kögel D
Neoplasia; 2018 Mar; 20(3):263-279. PubMed ID: 29462756
[TBL] [Abstract][Full Text] [Related]
36. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
[TBL] [Abstract][Full Text] [Related]
37. Proteomic analysis reveals a role for Bcl2-associated athanogene 3 and major vault protein in resistance to apoptosis in senescent cells by regulating ERK1/2 activation.
Pasillas MP; Shields S; Reilly R; Strnadel J; Behl C; Park R; Yates JR; Klemke R; Gonias SL; Coppinger JA
Mol Cell Proteomics; 2015 Jan; 14(1):1-14. PubMed ID: 24997994
[TBL] [Abstract][Full Text] [Related]
38. Unraveling the mystery: How bad is BAG3 in hematological malignancies?
Liu Q; Liu J; Huang X
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188781. PubMed ID: 35985611
[TBL] [Abstract][Full Text] [Related]
39. Structural Refinement of 2,4-Thiazolidinedione Derivatives as New Anticancer Agents Able to Modulate the BAG3 Protein.
Ruggiero D; Terracciano S; Lauro G; Pecoraro M; Franceschelli S; Bifulco G; Bruno I
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163936
[TBL] [Abstract][Full Text] [Related]
40. The stress protein BAG3 stabilizes Mcl-1 protein and promotes survival of cancer cells and resistance to antagonist ABT-737.
Boiani M; Daniel C; Liu X; Hogarty MD; Marnett LJ
J Biol Chem; 2013 Mar; 288(10):6980-90. PubMed ID: 23341456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
